Volume 46, Issue 3 , Pages 230-235, September 2007
Total hCG Versus Free β-hCG Combined with Alpha-fetoprotein for Down Syndrome Screening in Taiwan
Article Outline
Summary
Objective
The purpose of this study was to compare the effectiveness between total human chorionic gonadotropin (hCG) and free β-hCG in two-marker Down syndrome screening programs during the second trimester in a Taiwanese population.
Materials and Methods
From a multicenter collaborative study, we investigated the second-trimester maternal serum levels of total hCG from 67 data, free β-hCG from 72 and alpha-fetoprotein (AFP) from 96 obtained from Taiwanese pregnant women carrying fetuses with Down syndrome.
Results
High total hCG and free β-hCG, as well as low AFP levels, were found with median values of 2.06, 2.49 and 0.77 multiples of the median (MoM), respectively. At a 5% false-positive rate, total hCG and free β-hCG could detect 31% and 43% of Down syndrome pregnancies, respectively, whilst AFP alone could detect only 15% of affected cases. When combined with maternal age-specific risk, total hCG could achieve a 52% detection rate, free β-hCG a 54% and AFP a 39%. Combined total hCG and AFP achieved a detection rate of 55%, and combined free β-hCG and AFP achieved a rate of 60%.
Conclusion
The measurement of free β-hCG is more beneficial than total hCG in serum screening for Down syndrome during the second trimester of pregnancy.
Key Words: AFP , Asians , Down syndrome screening , free β-hCG , total hCG
No full text is available. To read the body of this article, please view the PDF online.
References
- . Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group . Obstet Gynecol . 1996;87:943–947
- . Maternal serum screening for Down syndrome in the United States: a 1995 survey . Am J Obstet Gynecol . 1996;176:1046–1051
- . Variation in biochemical screening for Down's syndrome in the United Kingdom . Br J Obstet Gynaecol . 1998;105:465–467
- Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin . Am J Obstet Gynecol . 1990;163:1248–1253
- . Evaluation of an assay of the free β-subunit of choriogonadotropin and its potential value in screening for Down's syndrome . Clin Chem . 1991;37:809–814
- . Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers . Ann Clin Biochem . 1992;29:506–518
- . The use of free β-hCG in antenatal screening for Down's syndrome . Br J Obstet Gynaecol . 1993;100:550–557
- . Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age . Prenat Diagn . 1997;17:707–716
- . Four-marker serum screening for Down's syndrome . Prenat Diagn . 1994;14:707–716
- . hCG and the free β-subunit as screening tests for Down syndrome . Prenat Diagn . 1998;18:235–245
- . Free β-hCG sub-unit versus intact hCG in Down syndrome screening . Obstet Gynecol . 1997;90:370–374
- . Is the measurement of unconjugated oestriol of value in screening for Down's syndrome . In: Grudzinskas JG , Chard T , Chapman M , Cuckle H editor. Screening for Down's Syndrome . Cambridge: Cambridge University Press; 1994;p. 141–161
- . Maternal serum alpha-fetoprotein levels between 13 and 24 weeks' gestation . Chang Gung Med J . 1994;17:309–315
- . Midtrimester human chorionic gonadotropin levels: Normal references values in Chinese pregnant women . Chang Gung Med J . 1995;18:240–247
- . Midtrimester maternal serum free beta-human chorionic gonadotropin levels: normal reference values for Taiwanese women . Chang Gung Med J . 1998;21:277–282
- . Influence of maternal age and weight on second-trimester serum alpha-fetoprotein, total and free beta human chorionic gonadotropin levels . Chang Gung Med J . 1997;20:181–186
- . Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level . Br J Obstet Gynaecol . 1987;94:387–402
- . The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy . Ann Clin Biochem . 1990;27:452–458
- . Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities . Prenat Diagn . 1987;7:623–630
- . Multiple-marker screening for fetal Down syndrome . Contemp Ob Gyn . 1992;4:3–12
- . Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong . Prenat Diagn . 1998;18:585–589
- . High maternal serum chorionic gonadotropin level in Down's syndrome pregnancies is caused by elevation of both sub-units messenger ribonucleic acid level in trophoblasts . J Clin Endocrinol Metab . 1995;80:3528–3531
- . Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses . Prenat Diagn . 1992;12:251–261
- Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome . Prenat Diagn . 1994;14:97–103
- . Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome . Lancet . 1984;1:926–929
- . Screening for Down's syndrome using serum α-fetoprotein: a retrospective study indicating caution . Br Med J (Clin Res Ed) . 1985;290:1940–1943
- . Provision of screening for Down's syndrome . BMJ . 1995;311:512–514
- . Free β-hCG as first-trimester marker for fetal trisomy . Lancet . 1992;339:1480–1481
- . First trimester serum screening for Down's syndrome . Prenat Diagn . 1995;15:1227–1240
PII: S1028-4559(08)60025-X
doi:10.1016/S1028-4559(08)60025-X
© 2007 Taiwan Association of Obstetric & Gynecology. Published by Elsevier Inc. All rights reserved.
Volume 46, Issue 3 , Pages 230-235, September 2007
